https://www.selleckchem.com/pr....oducts/defactinib.ht
Recent studies have focused on the correlation between N6-methyladenosine (m A) modification and specific tumor-infiltrating immune cells. However, the potential roles of m A modification in the tumor immune landscape remain elusive. We comprehensively evaluated the m A modification patterns and tumor immune landscape of 513 clear cell renal cell carcinoma (ccRCC) patients, and correlated the m A modification patterns with the immune landscape. The m6Ascore was established using principal component analysis. Multivariate Cox regressi
Like
Comment
Share
